Optimal dosing of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: a cross-sectional study in Palestine

Because high-dose angiotensin-converting enzyme (ACE) inhibitor therapy is desirable in patients with chronic heart failure (CHF), we sought to determine the usage and dosing patterns of ACE inhibitors in CHF patients at a governmental hospital in Palestine. This cross-sectional study was conducted...

Full description

Saved in:
Bibliographic Details
Published in:Annals of Saudi medicine 2009-03, Vol.29 (2), p.119-122
Main Authors: Sweileh, Waleed M, Sawalha, Ansam F, Rinno, Tamara M, Zyoud, Sa'ed H, Al-Jabi, Samah W
Format: Article
Language:English
Subjects:
ACE inhibitors
Aged
Angiotensin-Converting Enzyme Inhibitors - administration & dosage
Chi-Square Distribution
Chronic Disease
Clinical trials
Cross-Sectional Studies
Demographic aspects
Dosage and administration
Drug therapy
Female
Heart failure
Heart Failure - drug therapy
Humans
Male
Middle Aged
Middle East
Mortality
Original
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Because high-dose angiotensin-converting enzyme (ACE) inhibitor therapy is desirable in patients with chronic heart failure (CHF), we sought to determine the usage and dosing patterns of ACE inhibitors in CHF patients at a governmental hospital in Palestine. This cross-sectional study was conducted between September 2006 and August 2007. All patients admitted with a confirmed diagnosis of CHF and an ejection fraction
ISSN:0256-4947
0975-4466
DOI:10.4103/0256-4947.51794